Hyperprogressive disease rarely occurs during checkpoint inhibitor treatment for advanced melanoma

INTRODUCTION: Hyperprogression, characterized by a rapid acceleration in tumor growth, is a novel pattern of progression recently described in patients treated with immune checkpoint inhibitors. This study aims to assess the incidence of hyperprogression in patients with advanced melanoma treated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuiveling, M., Tonk, E. H. J., Verheijden, R. J., Suijkerbuijk, K. P. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053186/
https://www.ncbi.nlm.nih.gov/pubmed/32929554
http://dx.doi.org/10.1007/s00262-020-02716-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053186/
https://www.ncbi.nlm.nih.gov/pubmed/32929554
http://dx.doi.org/10.1007/s00262-020-02716-3

Ejemplares similares